U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sodium Bicarbonate Injection
Status: Currently in Shortage
»Date first posted: 03/01/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc. (Reverified 10/17/2025)

Company Contact Information:
800-423-4136

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1) Available

Exela Pharma Sciences, LLC (Revised 12/01/2025)

Company Contact Information:
828-758-5474 ext. 154

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5) Limited Availability Releasing weekly shipments to wholesalers Other
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4) Unavailable 2 weeks Demand increase for the drug
Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4) Unavailable, 2 weeks 2 weeks Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 11/19/2025)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05) Available Check wholesalers for inventory
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50) Available Check wholesalers for inventory

Hospira, Inc., a Pfizer Company (Reverified 11/26/2025)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 5 mEq/10 mL (4.2%, 0.5 mEq/mL) Syringes (NDC 0409-5534-14) Unavailable Discontinuation of the manufacture of the drug

Link to Discontinuation

 Discontinuation of the manufacture of the drug
Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-6637-14) Unavailable Discontinuation of the manufacture of the drug

Link to Discontinuation

 Discontinuation of the manufacture of the drug
Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02) Available
Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01) Limited Availability Limited Supply Available. Next Delivery: August 2026; Estimated Recovery: September 2026 Other
Sodium Bicarbonate, Injection, 44.6 mEq/50 mL (7.5%, 0.9 mEq/mL) Syringes (NDC 0409-4916-14) Unavailable Discontinuation of the manufacture of the drug

Link to Discontinuation

 Discontinuation of the manufacture of the drug
Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14) Available
Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35) Unavailable Next Delivery: July 2026; Estimated Recovery: September 2026 Other
Sodium Bicarbonate, Injection, 10 mEq/10 mL (8.4%, 1 mEq/mL) Syringes (NDC 0409-4900-14) Unavailable Discontinuation of the manufacture of the drug

Link to Discontinuation

 Discontinuation of the manufacture of the drug

Long Grove Pharmaceuticals LLC (Reverified 09/17/2025)

Company Contact Information:
833-268-5559

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3) Available
Back to Top